Researchers from Monell Chemical Senses Center have identified a specific population of neurons in the brain that could be ...
Pharmaceutical giant Roche is "fast-tracking" its own weight-loss pills in clinical trials as it looks to compete with Novo ...
People taking weight-loss drugs are spending less on groceries because their appetites have shrunk, according to a new study ...
The European Medicines Agency has backed the use of Novo Nordisk's Wegovy to lower major heart risks and strokes in ...
Wegovy presents an urgent challenge to the sustainability of Medicare and Medicaid, whose budgetary outlook under the status ...
Wegovy and other GLP-1 agonist obesity-fighting drugs could eventually improve people's health so much that they will hurt ...
Novo Nordisk's weight-loss drug Wegovy has secured the UK regulator's approval for its use to reduce the risk of overweight ...
Health regulators in the U.K. on Tuesday approved Novo Nordisk’s weight loss injection semaglutide—the active ingredient in ...
A new study has revealed that semaglutide, which is found in drugs such as Wegovy and Ozempic, could also play a role in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback